Whether it’s about your visit, the care you received, or our customer service.
HPTN087 is exploring the safety, tolerability, and efficacy of a broadly neutralizing antibody. This study completed the enrollment and is no longer accepting new participants. If this study interests you, we are currently enrolling for HVTN124, which is testing several HIV vaccines. We invite you to learn more and take the prescreener for HVTN124 here.
